Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Cell adhesion molecule 1

Introduction

Cell adhesion molecule 1 is a protein that, in humans, is encoded by the CADM1 gene.[1][2]

Model organisms

Model organisms

Model organisms have been used in the study of CADM1 function. A conditional knockout mouse line, called Cadm1tm1.2Brd[6] was generated.[7] Male and female animals underwent a standardized phenotypic screen to determine the effects of deletion.[5][8] Twenty six tests were carried out on homozygous mutant mice and one significant abnormality was observed: males were infertile.[5] Further analysis showed spermatogenesis had arrested in these mice.[7]

Interactions

Interactions

Cell adhesion molecule 1 has been shown to interact with EPB41L3.[9]

See also

See also

References

References

  1. ↑ Gomyo H, Arai Y, Tanigami A, Murakami Y, Hattori M, Hosoda F, Arai K, Aikawa Y, Tsuda H, Hirohashi S, Asakawa S, Shimizu N, Soeda E, Sakaki Y, Ohki M (Feb 2000). “A 2-Mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2”. Genomics. 62 (2): 139–46. doi:10.1006/geno.1999.6001. PMID 10610705.
  2. ↑ “Entrez Gene: CADM1 cell adhesion molecule 1”.
  3. ↑ “Salmonella infection data for Cadm1″. Wellcome Trust Sanger Institute.
  4. ↑ “Citrobacter infection data for Cadm1″. Wellcome Trust Sanger Institute.
  5. ↑ 5.0 5.1 5.2 Gerdin AK (2010). “The Sanger Mouse Genetics Programme: High throughput characterisation of knockout mice”. Acta Ophthalmologica. 88: 925–7. doi:10.1111/j.1755-3768.2010.4142.x.
  6. ↑ “Mouse Genome Informatics”.
  7. ↑ 7.0 7.1 Van Der Weyden, L.; Arends, M. J.; Chausiaux, O. E.; Ellis, P. J.; Lange, U. C.; Surani, M. A.; Affara, N.; Murakami, Y.; Adams, D. J.; Bradley, A. (2006). “Loss of TSLC1 Causes Male Infertility Due to a Defect at the Spermatid Stage of Spermatogenesis”. Molecular and Cellular Biology. 26 (9): 3595–3609. doi:10.1128/MCB.26.9.3595-3609.2006. PMC 1447413. PMID 16611999.
  8. ↑ van der Weyden L, White JK, Adams DJ, Logan DW (2011). “The mouse genetics toolkit: revealing function and mechanism”. Genome Biol. 12 (6): 224. doi:10.1186/gb-2011-12-6-224. PMC 3218837. PMID 21722353.
  9. ↑ Yageta, Mika; Kuramochi Masami; Masuda Mari; Fukami Takeshi; Fukuhara Hiroshi; Maruyama Tomoko; Shibuya Masabumi; Murakami Yoshinori (Sep 2002). “Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer”. Cancer Res. United States. 62 (18): 5129–33. ISSN 0008-5472. PMID 12234973.
Further reading

Further reading

  • Watabe K, Ito A, Koma YI, Kitamura Y (2004). “IGSF4: a new intercellular adhesion molecule that is called by three names, TSLC1, SgIGSF and SynCAM, by virtue of its diverse function”. Histol. Histopathol. 18 (4): 1321–9. PMID 12973698.
  • Kuramochi M, Fukuhara H, Nobukuni T, et al. (2001). “TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer”. Nat. Genet. 27 (4): 427–30. doi:10.1038/86934. PMID 11279526.
  • Masuda M, Yageta M, Fukuhara H, et al. (2002). “The tumor suppressor protein TSLC1 is involved in cell-cell adhesion”. J. Biol. Chem. 277 (34): 31014–9. doi:10.1074/jbc.M203620200. PMID 12050160.
  • Fukuhara H, Kuramochi M, Fukami T, et al. (2003). “Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer”. Jpn. J. Cancer Res. 93 (6): 605–9. doi:10.1111/j.1349-7006.2002.tb01297.x. PMID 12079507.
  • Allinen M, Peri L, Kujala S, et al. (2002). “Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation”. Genes Chromosomes Cancer. 34 (4): 384–9. doi:10.1002/gcc.10079. PMID 12112527.
  • Biederer T, Sara Y, Mozhayeva M, et al. (2002). “SynCAM, a synaptic adhesion molecule that drives synapse assembly”. Science. 297 (5586): 1525–31. Bibcode:2002Sci…297.1525B. doi:10.1126/science.1072356. PMID 12202822.
  • Yageta M, Kuramochi M, Masuda M, et al. (2002). “Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer”. Cancer Res. 62 (18): 5129–33. PMID 12234973.
  • Jansen M, Fukushima N, Rosty C, et al. (2003). “Aberrant methylation of the 5′ CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs”. Cancer Biol. Ther. 1 (3): 293–6. PMID 12432281.
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS…9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
  • Honda T, Tamura G, Waki T, et al. (2003). “Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines”. Jpn. J. Cancer Res. 93 (8): 857–60. doi:10.1111/j.1349-7006.2002.tb01329.x. PMID 12716461.
  • Shingai T, Ikeda W, Kakunaga S, et al. (2003). “Implications of nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cells”. J. Biol. Chem. 278 (37): 35421–7. doi:10.1074/jbc.M305387200. PMID 12826663.
  • Ito A, Okada M, Uchino K, et al. (2003). “Expression of the TSLC1 adhesion molecule in pulmonary epithelium and its down-regulation in pulmonary adenocarcinoma other than bronchioloalveolar carcinoma”. Lab. Invest. 83 (8): 1175–83. doi:10.1097/01.LAB.0000081391.28136.80. PMID 12920246.
  • Fukami T, Fukuhara H, Kuramochi M, et al. (2003). “Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines”. Int. J. Cancer. 107 (1): 53–9. doi:10.1002/ijc.11348. PMID 12925956.
  • Uchino K, Ito A, Wakayama T, et al. (2003). “Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung”. Cancer. 98 (5): 1002–7. doi:10.1002/cncr.11599. PMID 12942568.
  • Clark HF, Gurney AL, Abaya E, et al. (2003). “The Secreted Protein Discovery Initiative (SPDI), a Large-Scale Effort to Identify Novel Human Secreted and Transmembrane Proteins: A Bioinformatics Assessment”. Genome Res. 13 (10): 2265–70. doi:10.1101/gr.1293003. PMC 403697. PMID 12975309.
  • Fukuhara H, Masuda M, Yageta M, et al. (2003). “Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of Drosophila tumor suppressor Dlg”. Oncogene. 22 (40): 6160–5. doi:10.1038/sj.onc.1206744. PMID 13679854.
  • Ito T, Shimada Y, Hashimoto Y, et al. (2003). “Involvement of TSLC1 in progression of esophageal squamous cell carcinoma”. Cancer Res. 63 (19): 6320–6. PMID 14559819.
  • Mao X, Seidlitz E, Ghosh K, et al. (2004). “The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer”. Cancer Res. 63 (22): 7979–85. PMID 14633730.